Delivery Order SPE2DB24D1205-SPE2DB25FCZAX
Award Date 7/30/25
Potential Completion Date 8/20/25
Potential Value $2.2K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- AmerisourceBergen Drug Corp has been awarded a delivery order valued at $1,136.57 for LEQEMBI 200 mg/2 ml vials by the Department of Defense Medical Supply Chain on July 21, 2025. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of August 11, 2025, and will be performed at the company's corporate office in Conshohocken, Pennsylvania. This award was made through open competition with no set-aside designation. LEQEMBI is a specialized...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,186.60 firm fixed-price contract is for the delivery of LEQEMBI 500 MG/5 ML VIAL 5ML, a medical supply product. The contract has an ultimate completion date of July 1, 2025. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division,...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of a pharmaceutical product, LEQEMBI 500 MG/5 ML VIAL 5ML, with a ceiling value of $2,188.25. The contract is a Firm Fixed Price Delivery Order, with an ultimate completion date of June 13, 2025. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract...
- This federal contract award is for the delivery of LEQEMBI 500 MG/5 ML VIAL 5ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on February 27, 2025, with a ceiling value of $2,712.44 and a completion date of March 20, 2025. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of LEQEMBI 500 MG/5 ML VIAL 5ML, a pharmaceutical product, with a ceiling value of $1,312.95 and a period of performance through May 21, 2025. The contract is not set aside and is part of a larger Indefinite Delivery Contract (IDC) vehicle between AmerisourceBergen and DLA Troop...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,560.95 firm fixed-price delivery order is for the supply of LEQEMBI 500 MG/5 ML VIAL 5ML, a medication. The contract has an ultimate completion date of January 22, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The contract is for the supply of LEQEMBI 500 MG/5 ML VIAL 5ML, a pharmaceutical product, with a ceiling value of $1,792.50 and a completion date of October 18, 2024. The contract is a firm fixed price delivery order, and there is no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is the prime contractor on this award,...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of LEQEMBI 500 MG/5 ML vials. The contract has a ceiling value of $3,585.00 and a period of performance through October 31, 2024. AmerisourceBergen is a major pharmaceutical distributor that holds several Indefinite Delivery Contracts (IDCs) with federal agencies, including a $999,999,999 IDC with DLA Troop Support Medical for a wide range of medical...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Likmez 500 mg/5 mL suspension in a 200 mL quantity. This competitively awarded, firm fixed-price delivery order has a ceiling value of $2,298.44 and an ultimate completion date of August 6, 2025. The contract utilizes no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $23,255.50, is a delivery order for the medical product "LEQVIO 284 MG/1.5 ML SYRINGE 1.5ML". The contract is a Firm Fixed Price arrangement and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC)...